retatrutide type 2 diabetes trial nct Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a π A triple-action once-weekly injection
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18

























